Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.
about
Lung cancer signatures in plasma based on proteome profiling of mouse tumor modelsIdentification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancerQuantitative proteomics of complex mixtures.Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational researchThe proteome buccaneers: how to unearth your treasure chest via combinatorial peptide ligand libraries.Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum."The quest for biomarkers": are we on the right technical track?Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.Protein biomarkers of ovarian cancer: the forest and the treesDifferential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell LinesRecent insights into the actions of IGFBP-6.Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsOxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma.Cancer proteomics.Insulin-like growth factor-binding protein-6 and cancer.Proteomics applied to transfusion plasma: the beginning of the story.In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion.Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives.
P2860
Q24628852-DD9577A1-FC31-4CFD-973C-FD2AF544CC17Q28478197-7B67B46E-2C96-42D5-B1B2-187ECABBBBB2Q31039257-42BA9BCF-EBB1-46F2-B348-6EC145EC44D8Q33546659-851642E9-3BB8-42F2-B852-C5FF8E3361A5Q33576391-0C11A445-96E1-430B-A08B-0583D934F13CQ33600047-799D571F-30DD-4E14-B524-78D34C9BDE8FQ33945104-AEB72DB2-F296-485C-A577-034179374CEBQ34116103-0E2F6841-0ECC-40ED-A0D0-88E15451F076Q34166257-246A6BDF-1E1C-4FE3-B89C-927725B0FCECQ34173955-EB0BDB27-2D4C-4532-A741-862821285AD7Q34634143-E81148FC-18B5-4F52-811C-386352F8AA3EQ34818399-58E7ACCD-BCC9-47B6-88AB-499BEB7A9F4EQ35690623-8564F20D-C12B-46C4-A265-AE4B3A8F6C0DQ36362594-FAF518EA-8127-47A1-9329-58887C3FC275Q36452318-63D83B0B-78CE-4FDB-853A-56995A4A1657Q36889137-CAF69312-D830-4421-947C-E387CD34878EQ37009157-276D3091-044E-49F0-B58F-902CA63864FEQ37994133-5CF474EC-67BE-4D91-AD4B-37303ABE6B44Q38057775-6997CF26-9F5E-41B5-8399-0CBFF5C4990EQ38084362-BFABA4E4-169E-4653-8F66-D7A65E9289D9Q41361822-E4475B24-002A-47A8-A701-CEA8EC5A1539Q41601838-85F8E3E8-F17E-49DD-96F6-776A1BBBBB51Q41838773-0808FE5D-BF39-4A78-96FC-095CEC0FAA01Q50207576-874E9F28-CB39-43F1-9460-AB3BDE0DACC9
P2860
Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@ast
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@en
type
label
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@ast
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@en
prefLabel
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@ast
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@en
P2093
P2860
P356
P1476
Deep depletion of abundant ser ...... kers for human ovarian cancer.
@en
P2093
Biaoyang Lin
James T White
Lloyd J Old
Shashikant Lele
P2860
P304
P356
10.1002/PRCA.200800141
P577
2009-07-01T00:00:00Z